Treace Medical Concepts Profit Margin

The latest profit margin for TMCI is -29.44% as of March 2026. That compares with -25.13% in the prior-year period — down 17.1% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Treace Medical Concepts's historical trend and sector peers before judging valuation or financial health.

Over the past year, TMCI's profit margin moved from -25.13% to -29.44% — a 17.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Treace Medical Concepts's valuation or profitability profile.

Against Healthcare companies, TMCI currently prints -29.44% for profit margin, while the sector average sits near 15.29%. That is roughly 292.5% below the sector mean. Large gaps often invite a closer look at Treace Medical Concepts's growth, margins, and balance sheet.

Profit Margin shows how effectively Treace Medical Concepts converts resources into returns. At -29.44%, TMCI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -25.13% in the prior-year period — down 17.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TMCI's profit margin (-29.44%), review year-over-year change from -25.13%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.